Literature DB >> 30872100

Myocardial Functional Decline During Prolonged Ex Situ Heart Perfusion.

Sanaz Hatami1, Christopher W White1, Shubham Shan2, Alois Haromy3, Xiao Qi1, Martin Ondrus4, Alexandra Kinnear4, Sayed Himmat1, Evangelos Michelakis3, Jayan Nagendran5, Darren H Freed6.   

Abstract

BACKGROUND: Myocardial function declines in a time-dependent fashion during ex situ heart perfusion. Cell death and metabolic alterations may contribute to this phenomenon, limiting the safe perfusion period and the potential of ex situ heart perfusion to expand the donor pool. Our aim was to investigate the etiology of myocardial functional decline in ex situ perfused hearts.
METHODS: Cardiac function, apoptosis, effectors and markers of cell death, and metabolic function were assessed in healthy pig hearts perfused for 12 hours. These hearts were perfused in nonworking mode or working mode.
RESULTS: Cardiac function declined during ex situ heart perfusion regardless of perfusion mode but was significantly better preserved in the hearts perfused in working mode (11-hour cardiac index/1-hour cardiac index: working mode, 33%; nonworking mode, 10%; p = 0.025). The rate of apoptosis was higher in the ex situ perfused hearts compared with in vivo samples (apoptotic cells: in vivo, 0.13%; working mode, 0.54%; nonworking mode, 0.88%; p < 0.001), but the absolute values were low and out of proportion to the decline in function in either group. Myocardial dysfunction at the end of the perfusion interval was partially rescued by delivery of a pyruvate bolus.
CONCLUSIONS: A significant decline in myocardial function occurs over time in hearts preserved ex situ that is out of proportion to the magnitude of myocyte cell death present in dysfunctional hearts. Alterations in myocardial substrate utilization during prolonged ex situ heart perfusion may contribute to this phenomenon and represent an avenue to improve donor heart preservation.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30872100     DOI: 10.1016/j.athoracsur.2019.01.076

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  A Multi-Mode System for Myocardial Functional and Physiological Assessment during Ex Situ Heart Perfusion.

Authors:  Thomas Duignan; Alvise Guariento; Ilias P Doulamis; Takashi Kido; William L Regan; Mossab Saeed; David M Hoganson; Sitaram M Emani; Pedro J Del Nido; James D McCully; Gregory S Matte
Journal:  J Extra Corpor Technol       Date:  2020-12

2.  Dynamic Metabolic Changes During Prolonged Ex Situ Heart Perfusion Are Associated With Myocardial Functional Decline.

Authors:  Mariola Olkowicz; Roberto Vanin Pinto Ribeiro; Frank Yu; Juglans Souto Alvarez; Liming Xin; Miao Yu; Roizar Rosales; Mitchell Brady Adamson; Ved Bissoondath; Ryszard T Smolenski; Filio Billia; Mitesh Vallabh Badiwala; Janusz Pawliszyn
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

3.  Commentary: Planes, trains, and automobiles-Effective use of prolonged ex vivo heart preservation.

Authors:  Evan P Rotar; Irving L Kron
Journal:  J Card Surg       Date:  2021-03-30       Impact factor: 1.778

Review 4.  Inflammation and Oxidative Stress in the Context of Extracorporeal Cardiac and Pulmonary Support.

Authors:  Sanaz Hatami; Joshua Hefler; Darren H Freed
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

5.  Oxygenated machine perfusion at room temperature as an alternative for static cold storage in porcine donor hearts.

Authors:  Vincent van Suylen; Katrien Vandendriessche; Arne Neyrinck; Foppe Nijhuis; Arjan van der Plaats; Erik K Verbeken; Pieter Vermeersch; Bart Meyns; Massimo A Mariani; Filip Rega; Michiel E Erasmus
Journal:  Artif Organs       Date:  2021-10-31       Impact factor: 2.663

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.